136 related articles for article (PubMed ID: 7674345)
1. Ki-67 reactivity in breast carcinoma analyzed by a computer-assisted image system: preliminary results.
Mir R; Johnson H; Mathur R; Wise L; Kahn LB
J Natl Med Assoc; 1995 Aug; 87(8):554-9. PubMed ID: 7674345
[TBL] [Abstract][Full Text] [Related]
2. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Veronese SM; Maisano C; Scibilia J
Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
[TBL] [Abstract][Full Text] [Related]
3. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
[TBL] [Abstract][Full Text] [Related]
4. [Ki 67 growth fraction in carcinomas and benign lesions of the breast].
Kunz J; Schmidt A
Zentralbl Pathol; 1993 Aug; 139(3):201-5. PubMed ID: 8218121
[TBL] [Abstract][Full Text] [Related]
5. Quantitative immunohistochemistry using the CAS 200/486 image analysis system in invasive breast carcinoma: a reproducibility study.
Makkink-Nombrado SV; Baak JP; Schuurmans L; Theeuwes JW; van der Aa T
Anal Cell Pathol; 1995 Apr; 8(3):227-45. PubMed ID: 7547496
[TBL] [Abstract][Full Text] [Related]
6. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.
Haerslev T; Jacobsen GK; Zedeler K
Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.
Weidner N; Moore DH; Vartanian R
Hum Pathol; 1994 Apr; 25(4):337-42. PubMed ID: 8163266
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor in breast cancer: correlation of quantitative immunocytochemical assays to prognostic factors.
Charpin C; Devictor B; Bonnier P; Andrac L; Lavaut MN; Allasia C; Piana L
Breast Cancer Res Treat; 1993; 25(3):203-10. PubMed ID: 8369521
[TBL] [Abstract][Full Text] [Related]
9. A comparison between Ki-67 antibody reactivity and other pathological variables in breast carcinoma.
Bilous AM; McKay M; Milliken J
Pathology; 1991 Oct; 23(4):282-5. PubMed ID: 1664511
[TBL] [Abstract][Full Text] [Related]
10. [Effect of the proliferation rate on the course of node negative breast carcinoma].
Mitze M; Weikel W; Brumm C; Lippold R; Knapstein PG
Geburtshilfe Frauenheilkd; 1995 Jun; 55(6):299-305. PubMed ID: 7657137
[TBL] [Abstract][Full Text] [Related]
11. Correlation of proliferative index (PCNA reactivity and Ki-67 reactivity) in primary breast carcinoma with hormone status, lymph node status, and disease-free survival.
Magno WB; Hirschfield L; Bhuiya T; Harrison G; Mir R
Conn Med; 1992 Dec; 56(12):667-9. PubMed ID: 1363223
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical quantification of steroid receptors and other prognosis factors in human breast cancer patients.
Fritz P; Tuczek HV; Offinger B; Schwarzmann P; Schieszl S; Wu X; Kleine B; Blödorn J; Multhaupt H
Prog Histochem Cytochem; 1992; 26(1-4):146-58. PubMed ID: 1283015
[No Abstract] [Full Text] [Related]
13. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
14. Determination of Ki67 growth fraction and oestrogen receptors in screen-detected breast cancer using cytological preparations.
Coddington R; Cuthbert A; Campbell ID; Herbert A; Theaker JM; Royle GT; Taylor I
Cytopathology; 1993; 4(5):257-66. PubMed ID: 8274663
[TBL] [Abstract][Full Text] [Related]
15. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
[TBL] [Abstract][Full Text] [Related]
16. Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic features.
Veronese SM; Gambacorta M
Am J Clin Pathol; 1991 Jan; 95(1):30-4. PubMed ID: 1987749
[TBL] [Abstract][Full Text] [Related]
17. Hormonal receptors, cell proliferation fraction (Ki-67) and c-erbB-2 amplification in breast cancer. Relationship between differentiation degree and axillary lymph node metastases.
Sirvent JJ; Santafé M; Salvadó MT; Alvaro T; Raventós A; Palacios J
Histol Histopathol; 1994 Jul; 9(3):563-70. PubMed ID: 7526910
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of different methods for determination of proliferative activity of breast carcinomas].
Mink D; Villena-Heinsen C; Tossounidis I; Schmidt W
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():53-6. PubMed ID: 8672927
[TBL] [Abstract][Full Text] [Related]
19. Immunodetection of HER-2/neu protein in frozen sections evaluated by image analysis: correlation with overall and disease-free survival in breast carcinomas.
Charpin C; Bonnier P; Devictor B; Andrac L; Lavaut MN; Allasia C; Piana L
Anticancer Res; 1993; 13(3):603-12. PubMed ID: 8100412
[TBL] [Abstract][Full Text] [Related]
20. Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis.
Rudas M; Gnant MF; Mittlböck M; Neumayer R; Kummer A; Jakesz R; Reiner G; Reiner A
Breast Cancer Res Treat; 1994; 32(2):165-75. PubMed ID: 7865846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
